Recro Pharma Acquires IRISYS (San Diego)
August 13, 2021
Recro Pharma (NASDAQ: REPH) acquired San Diego–based CDMO IRISYS for approximately $49.85 million in cash, stock and a seller promissory note, transforming Recro into a bi‑coastal, full‑service CDMO. The acquisition expands Recro's capabilities (including aseptic fill/finish and lyophilization), diversifies its client base and adds near‑term revenue and backlog.
- Buyers
- Recro Pharma, Inc.
- Targets
- IRISYS
- Sellers
- EPS Americas, Corp., IriSys, Inc., Continent Pharmaceuticals U.S., Inc.
- Industry
- Pharmaceuticals
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.